Skip to main content
. 2020 Dec 19;104:7–14. doi: 10.1016/j.ijid.2020.12.041

Figure 2.

Figure 2

Association of previously administered medications with the risk of COVID-19 and severity.

(A) Risk of COVID-19 among tested individuals. (B) Risk of severe disease among patients with COVID-19. Severe disease was defined as the requirement of any one of the following or death: supplementary oxygen, high-flow nasal cannula, non-invasive ventilation, mechanical ventilation, and extracorporeal membrane oxygenation.